Correlation Between Enveric Biosciences and Ginkgo Bioworks
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Enveric Biosciences and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Ginkgo Bioworks.
Diversification Opportunities for Enveric Biosciences and Ginkgo Bioworks
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enveric and Ginkgo is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Ginkgo Bioworks go up and down completely randomly.
Pair Corralation between Enveric Biosciences and Ginkgo Bioworks
Given the investment horizon of 90 days Enveric Biosciences is expected to generate 0.73 times more return on investment than Ginkgo Bioworks. However, Enveric Biosciences is 1.37 times less risky than Ginkgo Bioworks. It trades about -0.1 of its potential returns per unit of risk. Ginkgo Bioworks Holdings is currently generating about -0.08 per unit of risk. If you would invest 90.00 in Enveric Biosciences on September 13, 2024 and sell it today you would lose (54.46) from holding Enveric Biosciences or give up 60.51% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Enveric Biosciences vs. Ginkgo Bioworks Holdings
Performance |
Timeline |
Enveric Biosciences |
Ginkgo Bioworks Holdings |
Enveric Biosciences and Ginkgo Bioworks Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enveric Biosciences and Ginkgo Bioworks
The main advantage of trading using opposite Enveric Biosciences and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
Ginkgo Bioworks vs. Ocean Biomedical | Ginkgo Bioworks vs. Enveric Biosciences | Ginkgo Bioworks vs. Hepion Pharmaceuticals | Ginkgo Bioworks vs. Elevation Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |